Neurocrine Biosciences

Today we presented subgroup analyses and data from the KINECT®-HD study evaluating the emotional health and psychiatric stability in patients with chorea associated with Huntington’s disease. https://lnkd.in/gGm_QzWk Huntington Study Group #HSG2024

As our newly appointed CEO, Kyle W. Gano, Ph.D., shared his enthusiasm for Neurocrine’s future on our Q3 2024 #EarningsCall. ICYMI, you can read the transcript here: https://lnkd.in/g6wZX4bQ $NBIX

Today we held our Q3 2024 #EarningsCall. Read our financial results here: https://lnkd.in/g-eurFXp $NBIX

We are closing enrollment on our 2025-2027 University of Southern California - Neurocrine Biosciences Postdoctoral Fellowship Program on November 30th. Apply today for one of our fellowship opportunities on our Medical and Clinical teams. Upon completion of the program, fellows will be more prepared for a career in the pharmaceutical industry within their respective functional areas. If you were unable to attend one of our informational webinars, we are hosting a third webinar on Wednesday, October 23rd from 5:00PM – 6:00PM PT/ 8:00PM – 9:00PM ET. Register today: https://lnkd.in/gYXtXkrr

Today marks the beginning of a new chapter for Neurocrine as Kyle W. Gano steps into his role as CEO. Under Kyle’s leadership, we will continue working tirelessly to develop life-changing, innovative treatments for people with great needs, but few options. Join us in extending a warm welcome to Kyle on his first day as CEO! 

Today is World Mental Health Day, a time to raise awareness of mental health issues around the world and to mobilize efforts in support of mental health. The day provides an opportunity for all stakeholders working on mental health issues to talk about their work and what more needs to be done to make mental health care a reality for people worldwide. #MentalIllnessAwarenessWeek

Physician assistants are licensed clinicians who practice medicine in every specialty and setting. Trusted, rigorously educated and trained healthcare professionals, PAs are dedicated to expanding access to care and transforming health and wellness through patient-centered, team-based medical practice. This Physician Assistant Week, we honor their contributions to patient care. #PAweek #PAsGoBeyond

Neurocrine is proud to support Physician Assistant Week and to recognize the vital role PAs play in addressing patient needs. PAs are valuable contributors to the mental health care system, delivering high-quality, comprehensive care to individuals in need. Their expertise and compassion make a difference every day. #PAweek #PAsGoBeyond

Today is World Cerebral Palsy Day, a time to bring together people living with cerebral palsy, their families and supporters. Dyskinetic Cerebral Palsy is a form of cerebral palsy that is associated with a range of developmental delays, difficulties with physical function and involuntary movements. The Kinect-DCP Study is currently enrolling children, adolescents and adults, ages 6 – 70. The study is designed to determine if an investigational treatment can potentially improve involuntary movements that are difficult to control (dyskinesia) due to cerebral palsy (CP). Learn more: KinectDCPResearchTrial.com

We are excited to announce that enrollment for our 2025-2027 University of Southern California - Neurocrine Biosciences Postdoctoral Fellowship Program will open on October 10th. The fellowship program will provide training activities that support company goals, as well as developmental opportunities through broad-based, hands-on experience and mentorships that integrate our fellows into several strategic, medical initiatives. To learn more, register for one of our two upcoming informational webinars: https://lnkd.in/gYXtXkrr Wednesday, October 9 from 5:00PM – 6:00PM PT/ 8:00PM – 9:00PM ET Wednesday, October 23 from 5:00PM – 6:00PM PT/ 8:00PM – 9:00PM ET